Home › Research › Digital health tools
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA et al.. Annals of neurology, 2019-01-07
Topic: Brain proteins, microglia and lab models
Plain-language summary
Objective To use digital histology in a large autopsy cohort of Lewy body disorder (LBD) patients with dementia to test the hypotheses that co-occurring Alzheimer disease (AD) pathology impacts the anatomic distribution of α-synuclein (SYN) pathology and that co-occurring neocortical tau pathology in LBDs associates with worse cognitive performance and occurs in a pattern differing from AD. Methods Fifty-five autopsy-confirmed LBD (Parkinson disease with dementia, n = 36; dementia with Lewy bodies, n = 19) patients and 25 AD patients were studied. LBD patients were categorized as having moderate/severe AD copathology (SYN + AD = 20) or little/no AD copathology (SYN-AD = 35). Digital measures of tau, β-amyloid (Aβ), and SYN histopathology in neocortical and subcortical/limbic regions were compared between groups and related to antemortem cognitive testing. Results SYN burden was higher in SYN + AD than SYN-AD in each neocortical region (F 1, 54 = 5.6-6.0, p 1, 43-49 = 0.7-1.7, p > 0.2). SYN + AD performed worse than SYN-AD on a temporal lobe-mediated naming task (t 27 = 2.1, p = 0.04). Antemortem cognitive test scores inversely correlated with tau burden (r = -0.39 to -0.68, p 1, 43 = 12.8-97.2, p 41 = 2.0, p 41 = 3.3, p 1, 40-43 = 1.6-2.0, p > 0.1). Interpretation LBD patients with AD copathology harbor greater neocortical SYN pathology. Regional tau pathology relates to cognitive performance in LBD dementia, and its distribution may diverge from pure AD. Tau copathology contributes uniquely to the heterogeneity of cognitive impairment in LBD. Ann Neurol 2018; 1-13 ANN NEUROL 2019;85:259-271.
What this study adds
Evidence grade: Moderate
The record lists 36 participants. In people with Lewy body disorders, those who also had Alzheimer's disease pathology had more alpha-synuclein pathology in the brain and did worse on a naming task. This is an autopsy study describing how co-occurring pathologies relate to thinking problems, not a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Coughlin, D., Xie, S. X., Liang, M., Williams, A., Peterson, C., Weintraub, D., et al. (2019). Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders. Annals of neurology. https://doi.org/10.1002/ana.25392
Vancouver
Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, et al. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders. Annals of neurology. 2019. doi:10.1002/ana.25392. PMID: 30549331.
BibTeX
@article{coughlin2019-30549331,
author = {Coughlin, D. and Xie, S. X. and Liang, M. and Williams, A. and Peterson, C. and Weintraub, D. and McMillan, C. T. and Wolk, D. A. and others},
title = {{Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders}},
journal = {Annals of neurology},
year = {2019},
doi = {10.1002/ana.25392},
pmid = {30549331},
url = {https://doi.org/10.1002/ana.25392}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results SYN burden was higher in SYN + AD than SYN-AD in each neocortical region (F 1, 54 = 5.6-6.0, p 1, 43-49 = 0.7-1.7, p > 0.2).
Why it matters
In people with Lewy body disorders, those who also had Alzheimer's disease pathology had more alpha-synuclein pathology in the brain and did worse on a naming task. This is an autopsy study describing how co-occurring pathologies relate to thinking problems, not a treatment or cure.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Participants36
- Evidence strengthModerate
How this study scored 57/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Annals of neurology) |
| Journal's citation record | 3 / 4 | Annals of Neurology: journal h-index 437 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2019 — within 10 year(s) of the newest study here |
| Sample size | 1 / 4 | 36 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 148 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 16.4 citations a year over 9 year(s) since 2019 |
| Impact for its field and year | 4 / 6 | Cited 8.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 19 other studies in this library |
| Still being cited | 3 / 4 | Cited 60 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author David John Irwin: h-index 76 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Pennsylvania: institution h-index 1,859 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 30549331) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 27.
Later studies that cite this one
19 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Digital health tools from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.